- Home
- MTAL vs CRMD Comparison
MTAL vs CRMD Comparison
Compare MTAL & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTAL
- CRMD
- Stock Information
- Founded
- MTAL 2021
- CRMD 2006
- Country
- MTAL Jersey
- CRMD United States
- Employees
- MTAL N/A
- CRMD N/A
- Industry
- MTAL Blank Checks
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- MTAL Finance
- CRMD Health Care
- Exchange
- MTAL Nasdaq
- CRMD Nasdaq
- Market Cap
- MTAL 1.0B
- CRMD 865.2M
- IPO Year
- MTAL 2021
- CRMD 2010
- Fundamental
- Price
- MTAL $12.22
- CRMD $10.98
- Analyst Decision
- MTAL Hold
- CRMD Strong Buy
- Analyst Count
- MTAL 4
- CRMD 8
- Target Price
- MTAL $12.08
- CRMD $17.57
- AVG Volume (30 Days)
- MTAL 1.1M
- CRMD 2.6M
- Earning Date
- MTAL 11-09-2025
- CRMD 10-29-2025
- Dividend Yield
- MTAL N/A
- CRMD N/A
- EPS Growth
- MTAL N/A
- CRMD N/A
- EPS
- MTAL N/A
- CRMD 0.79
- Revenue
- MTAL $321,804,000.00
- CRMD $121,484,498.00
- Revenue This Year
- MTAL $17.15
- CRMD $480.51
- Revenue Next Year
- MTAL $24.95
- CRMD $59.81
- P/E Ratio
- MTAL N/A
- CRMD $13.90
- Revenue Growth
- MTAL N/A
- CRMD 14970.29
- 52 Week Low
- MTAL $7.69
- CRMD $5.60
- 52 Week High
- MTAL $13.88
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- MTAL 64.99
- CRMD 41.63
- Support Level
- MTAL $12.20
- CRMD $11.05
- Resistance Level
- MTAL $12.23
- CRMD $11.71
- Average True Range (ATR)
- MTAL 0.02
- CRMD 0.47
- MACD
- MTAL -0.00
- CRMD 0.01
- Stochastic Oscillator
- MTAL 75.00
- CRMD 8.21
About MTAL Metals Acquisition Limited
MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.